Literature DB >> 21691102

The bile acid membrane receptor TGR5: a valuable metabolic target.

Thijs W H Pols1, Lilia G Noriega, Mitsunori Nomura, Johan Auwerx, Kristina Schoonjans.   

Abstract

Bile acids (BAs) are amphipathic molecules that facilitate the uptake of lipids, and their levels fluctuate in the intestines as well as in the circulation depending on food intake. Besides their role in dietary lipid absorption, BAs function as signaling molecules that activate specific BA receptors and trigger downstream signaling cascades. The BA receptors and the signaling pathways they control are not only important in the regulation of BA synthesis and their metabolism, but they also regulate glucose homeostasis, lipid metabolism and energy expenditure - processes relevant in the context of the metabolic syndrome. In addition to the function of the nuclear receptor FXRα in regulating local effects of BAs in the organs of the enterohepatic axis, increasing evidence points to a crucial role of the G-protein-coupled receptor TGR5 in mediating systemic actions of BAs. Here we review the current knowledge on BA receptors, with a strong focus on the cell membrane receptor TGR5, which has emerged as a promising target for intervention in metabolic diseases.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691102      PMCID: PMC3128138          DOI: 10.1159/000324126

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  69 in total

1.  Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system.

Authors:  D P Poole; C Godfrey; F Cattaruzza; G S Cottrell; J G Kirkland; J C Pelayo; N W Bunnett; C U Corvera
Journal:  Neurogastroenterol Motil       Date:  2010-03-12       Impact factor: 3.598

2.  Pharmacophore model for bile acids recognition by the FPR receptor.

Authors:  Cristina Ferrari; Antonio Macchiarulo; Gabriele Costantino; Roberto Pellicciari
Journal:  J Comput Aided Mol Des       Date:  2006-09-14       Impact factor: 3.686

3.  Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice.

Authors:  Galya Vassileva; Weiwen Hu; Lizbeth Hoos; Glen Tetzloff; Shijun Yang; Li Liu; Ling Kang; Harry R Davis; Joseph A Hedrick; Hong Lan; Timothy Kowalski; Eric L Gustafson
Journal:  J Endocrinol       Date:  2010-03-30       Impact factor: 4.286

4.  Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells.

Authors:  Hiroshi Yasuda; Shuko Hirata; Kazuaki Inoue; Hirosato Mashima; Hirohide Ohnishi; Makoto Yoshiba
Journal:  Biochem Biophys Res Commun       Date:  2006-12-29       Impact factor: 3.575

5.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice.

Authors:  Takaharu Maruyama; Kenichi Tanaka; Jun Suzuki; Hiroyuki Miyoshi; Naomoto Harada; Takao Nakamura; Yasuhisa Miyamoto; Akio Kanatani; Yoshitaka Tamai
Journal:  J Endocrinol       Date:  2006-10       Impact factor: 4.286

6.  The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells.

Authors:  Verena Keitel; Roland Reinehr; Petros Gatsios; Claudia Rupprecht; Boris Görg; Oliver Selbach; Dieter Häussinger; Ralf Kubitz
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Metabolic networks of longevity.

Authors:  Riekelt H Houtkooper; Robert W Williams; Johan Auwerx
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

8.  Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis.

Authors:  Moreshwar S Desai; Zainuer Shabier; Michael Taylor; Fong Lam; Sundararajah Thevananther; Astrid Kosters; Saul J Karpen
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

9.  Regulation of bile acid synthesis by fat-soluble vitamins A and D.

Authors:  Daniel R Schmidt; Sam R Holmstrom; Klementina Fon Tacer; Angie L Bookout; Steven A Kliewer; David J Mangelsdorf
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

10.  A bile acid-like steroid modulates Caenorhabditis elegans lifespan through nuclear receptor signaling.

Authors:  Birgit Gerisch; Veerle Rottiers; Dongling Li; Daniel L Motola; Carolyn L Cummins; Hans Lehrach; David J Mangelsdorf; Adam Antebi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

View more
  47 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population.

Authors:  Min-Sun Kwak; Donghee Kim; Goh Eun Chung; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 3.  Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?

Authors:  M Chondronikola; L L S Harris; S Klein
Journal:  J Intern Med       Date:  2016-10-14       Impact factor: 8.989

Review 4.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

5.  Bile Acid Administration Elicits an Intestinal Antimicrobial Program and Reduces the Bacterial Burden in Two Mouse Models of Enteric Infection.

Authors:  Sarah Tremblay; Guillaume Romain; Mélisange Roux; Xi-Lin Chen; Kirsty Brown; Deanna L Gibson; Sheela Ramanathan; Alfredo Menendez
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

Review 6.  Interaction of gut microbiota with bile acid metabolism and its influence on disease states.

Authors:  Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Alexa R Weingarden
Journal:  Appl Microbiol Biotechnol       Date:  2016-11-25       Impact factor: 4.813

7.  Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.

Authors:  Eun Sun Jang; Jung-Hwan Yoon; Sung-Hee Lee; Soo-Mi Lee; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Hyo-Suk Lee; Chung Yong Kim
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

8.  Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion.

Authors:  Pablo Quintero; Margarita Pizarro; Nancy Solís; Juan Pablo Arab; Oslando Padilla; Arnoldo Riquelme; Marco Arrese
Journal:  J Physiol Biochem       Date:  2014-05-10       Impact factor: 4.158

9.  Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.

Authors:  Matthew J Potthoff; Austin Potts; Tianteng He; João A G Duarte; Ronald Taussig; David J Mangelsdorf; Steven A Kliewer; Shawn C Burgess
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

10.  Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.

Authors:  Ajay Kumar Jain; Abhineet Sharma; Sumit Arora; Keith Blomenkamp; Ik Chan Jun; Robert Luong; David John Westrich; Aayush Mittal; Paula M Buchanan; Miguel A Guzman; John Long; Brent A Neuschwander-Tetri; Jeffery Teckman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-08-20       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.